Plain-language summary
A formulation-oriented review that examines carnosine's stability, bioavailability ceiling, and ingredient compatibility, then considers whether functional-food matrices can deliver clinically meaningful doses given the dipeptide's rapid hydrolysis in plasma.
Key takeaways
- ›Honest about the bioavailability ceiling.
- ›Useful for product development decisions.
- ›Reinforces the case for non-oral delivery routes.
About this summary
The summary and key takeaways above are written by our editorial team in plain language for general readers. They are not the original abstract. For the authors' own wording, methodology, statistics, and full reference list, follow the source link to the published record.
